Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study.
作者信息
Donovan Jacqueline, Al Hamarneh Yazid N, Bajorek Beata, Papastergiou John, Tsuyuki Ross T
机构信息
Graduate School of Health (Pharmacy), The University of Technology Sydney (Donovan, Bajorek), Broadway NSW, Australia.
EPICORE Centre, Faculty of Medicine and Dentistry (Al Hamarneh, Tsuyuki), University of Alberta, Edmonton, Alberta.
出版信息
Can Pharm J (Ott). 2020 Feb 13;153(2):84-87. doi: 10.1177/1715163520902495. eCollection 2020 Mar-Apr.
Abstract
摘要
相似文献
1
Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study.社区药剂师使用即时检验技术识别慢性肾脏病：一项试点研究。
Can Pharm J (Ott). 2020 Feb 13;153(2):84-87. doi: 10.1177/1715163520902495. eCollection 2020 Mar-Apr.
2
Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.利用药剂师改善3A期慢性肾脏病的风险分层与管理：一项可行性研究
BMC Nephrol. 2016 Nov 8;17(1):168. doi: 10.1186/s12882-016-0383-7.
3
Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.由社区药剂师主导的干预措施，以识别未接受他汀类药物治疗的糖尿病患者。
J Am Pharm Assoc (2003). 2018 Jul-Aug;58(4S):S125-S130. doi: 10.1016/j.japh.2018.05.010.
4
Use of chronic disease management algorithms in Australian community pharmacies.澳大利亚社区药房中慢性病管理算法的应用。
Res Social Adm Pharm. 2015 Mar-Apr;11(2):176-96. doi: 10.1016/j.sapharm.2014.06.002. Epub 2014 Jun 18.
5
Attitudes of the general public to the expanding role of community pharmacists: a pilot study.
Fam Pract. 2001 Oct;18(5):534-6. doi: 10.1093/fampra/18.5.534.
6
Community pharmacist led, employer-based wellness services: A pilot study.社区药剂师主导的、雇主为基础的健康服务：一项试点研究。
Res Social Adm Pharm. 2019 May;15(5):615-618. doi: 10.1016/j.sapharm.2018.06.008. Epub 2018 Jun 12.
7
Effects of pharmacist participation in chronic kidney disease (CKD) network and CKD manual distribution on drug-related kidney injury.药师参与慢性肾脏病（CKD）网络和 CKD 手册分发对药物相关肾损伤的影响。
Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):887-896. doi: 10.1002/pds.4787. Epub 2019 Apr 30.
8
Evaluation of community pharmacy tech-check-tech as a strategy for practice advancement.评估社区药房技术人员相互检查作为实践推进策略的效果。
J Am Pharm Assoc (2003). 2018 Nov-Dec;58(6):652-658. doi: 10.1016/j.japh.2018.06.018. Epub 2018 Aug 29.
9
Community pharmacy transition of care services and rural hospital readmissions: A case study.社区药房护理服务过渡与农村医院再入院情况：一项案例研究。
J Am Pharm Assoc (2003). 2017 May-Jun;57(3S):S252-S258.e3. doi: 10.1016/j.japh.2017.02.019. Epub 2017 Apr 12.
10
Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).POINT研究的设计：通过在基层医疗团队中纳入非配药药剂师实现药物治疗优化（POINT）。
BMC Fam Pract. 2015 Jul 2;16:76. doi: 10.1186/s12875-015-0296-8.
引用本文的文献
1
Improving medication safety and prescribing of higher-risk medications in individuals with chronic kidney disease: A validation study.改善慢性肾脏病患者的用药安全性及高风险药物的处方开具：一项验证性研究。
Can Pharm J (Ott). 2025 Aug 22:17151635251357969. doi: 10.1177/17151635251357969.
2
Risk Factor-Based Screening for Early Detection of Chronic Kidney Disease in Primary Care Settings: A Systematic Review.基层医疗环境中基于风险因素的慢性肾脏病早期检测筛查：一项系统评价
Kidney Med. 2025 Feb 12;7(4):100979. doi: 10.1016/j.xkme.2025.100979. eCollection 2025 Apr.
3
Effect of pharmacist interventions in chronic kidney disease: a meta-analysis.药剂师干预对慢性肾脏病的影响：一项荟萃分析。
Nephrol Dial Transplant. 2025 Apr 28;40(5):884-907. doi: 10.1093/ndt/gfae221.
4
[Screening for Chronic Kidney Disease in the Community Pharmacy. CRIERFAC Study: Description of the Methodology].[社区药房慢性肾脏病筛查。CRIERFAC研究：方法学描述]
Farm Comunitarios. 2024 Apr 11;16(2):5-13. doi: 10.33620/FC.2173-9218.(2024).12. eCollection 2024 Apr 15.
5
Community Point of Care Testing in Diagnosing and Managing Chronic Kidney Disease.社区即时检测在慢性肾脏病诊断与管理中的应用
Diagnostics (Basel). 2024 Jul 17;14(14):1542. doi: 10.3390/diagnostics14141542.
6
Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients.社区药剂师主导的即时 eGFR 筛查：高危患者的慢性肾脏病早期检测。
Sci Rep. 2024 Mar 27;14(1):7284. doi: 10.1038/s41598-024-56765-0.
7
Impact of a pharmacy-led screening and intervention in people at risk of or living with chronic kidney disease in a primary care setting: a cluster randomised trial protocol.在基层医疗环境中，由药剂师主导的针对慢性肾脏病高危人群或患者的筛查和干预的效果：一项群组随机试验方案。
BMJ Open. 2023 Dec 20;13(12):e079110. doi: 10.1136/bmjopen-2023-079110.
8
Evaluation of Point-of-Care Testing in Pharmacy to Inform Policy Writing by the New Brunswick College of Pharmacists.新不伦瑞克药剂师学院对药房即时检验进行评估以指导政策制定。
Pharmacy (Basel). 2022 Nov 26;10(6):159. doi: 10.3390/pharmacy10060159.
9
Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.社区药房中慢性肾脏病患者的药学监护计划：检测肾毒性药物和剂量调整。可行性研究。
PLoS One. 2022 Dec 22;17(12):e0278648. doi: 10.1371/journal.pone.0278648. eCollection 2022.
本文引用的文献
1
Barriers to a full scope of pharmacy practice in primary care: A systematic review of pharmacists' access to laboratory testing.基层医疗中全面药学实践的障碍：对药剂师进行实验室检测权限的系统评价
Can Pharm J (Ott). 2019 Aug 6;152(5):317-333. doi: 10.1177/1715163519865759. eCollection 2019 Sep-Oct.
2
The global burden of chronic kidney disease: estimates, variability and pitfalls.全球慢性肾脏病负担：估计值、变异性和陷阱。
Nat Rev Nephrol. 2017 Feb;13(2):104-114. doi: 10.1038/nrneph.2016.163. Epub 2016 Dec 12.
3
Community pharmacist targeted screening for chronic kidney disease.社区药剂师针对慢性肾脏病的筛查
Can Pharm J (Ott). 2016 Jan;149(1):13-7. doi: 10.1177/1715163515618421.
4
Online clinical pathway for managing adults with chronic kidney disease.成人慢性肾脏病管理的在线临床路径
Can Pharm J (Ott). 2015 Sep;148(5):257-62. doi: 10.1177/1715163515597243.
5
Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey.加拿大慢性肾脏病的患病率估计：一项全国代表性调查的结果。
CMAJ. 2013 Jun 11;185(9):E417-23. doi: 10.1503/cmaj.120833. Epub 2013 May 6.
6
Evaluation of the analytical performance of the nova StatSensor creatinine meter for blood testing.评估用于血液检测的诺瓦 StatSensor 肌酐仪的分析性能。
J Med Assoc Thai. 2012 Sep;95(9):1225-31.
7
Evaluation of a handheld creatinine measurement device for real-time determination of serum creatinine in radiology departments.一款用于放射科实时测定血清肌酐的手持式肌酐测量设备的评估。
World J Radiol. 2012 Jul 28;4(7):328-34. doi: 10.4329/wjr.v4.i7.328.
8
Assessing renal function with a rapid, handy, point-of-care whole blood creatinine meter before using contrast materials.使用对比材料前，使用快速、方便、即时的全血肌酐测定仪评估肾功能。
Jpn J Radiol. 2011 Apr;29(3):187-93. doi: 10.1007/s11604-010-0536-8. Epub 2011 Apr 26.
9
Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease.评估 Nova StatSensor 全血即时检测肌酐分析仪在慢性肾脏病筛查中评估肾功能的价值。
Clin Chem Lab Med. 2010 Aug;48(8):1113-9. doi: 10.1515/CCLM.2010.238.
10
Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing.评价 Nova StatSensor 肌酐测定仪及全血检测试剂条技术的分析性能。
Clin Biochem. 2010 Aug;43(12):1026-9. doi: 10.1016/j.clinbiochem.2010.04.055. Epub 2010 Apr 21.
Zotero 插件